AVITA Medical, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
AVITA Medical, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2018 to Q2 2024.
  • AVITA Medical, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$15.4M, a 48.2% decline year-over-year.
  • AVITA Medical, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$49.8M, a 63.1% decline year-over-year.
  • AVITA Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$35.4M, a 32.7% decline from 2022.
  • AVITA Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$26.7M, a 0.31% decline from 2021.
  • AVITA Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$26.6M, a 36.8% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$49.8M -$15.4M -$5.01M -48.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$44.8M -$18.7M -$9.44M -102% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$35.4M -$7.07M -$1.71M -32% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 -$33.7M -$8.71M -$3.12M -55.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$30.5M -$10.4M -$4.12M -65.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$26.4M -$9.22M +$243K +2.57% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$26.7M -$5.35M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$5.59M +$360K +6.05% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$6.26M -$1.54M -32.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$9.46M -$3.47M -57.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 -$22.3M -$5.95M +$4.28M +41.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$26.6M -$4.72M +$8.2M +63.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$34.8M -$6M +$9.05M +60.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$43.8M -$5.64M +$4.86M +46.3% Oct 1, 2020 Dec 31, 2020 10-K 2021-08-26
Q3 2020 -$48.7M -$10.2M -$6.66M -187% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$42M -$12.9M -$5.29M -69.5% Apr 1, 2020 Jun 30, 2020 10-K 2021-08-26
Q1 2020 -$36.7M -$15M -$8.87M -143% Jan 1, 2020 Mar 31, 2020 10-K 2021-08-26
Q4 2019 -$27.9M -$10.5M -$4.24M -67.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-08-26
Q3 2019 -$23.6M -$3.57M +$1.47M +29.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-08-26
Q2 2019 -$25.1M -$7.62M Apr 1, 2019 Jun 30, 2019 10-K 2020-08-27
Q1 2019 -$6.18M Jan 1, 2019 Mar 31, 2019 10-K 2020-08-27
Q4 2018 -$6.27M Oct 1, 2018 Dec 31, 2018 10-K 2020-08-27
Q3 2018 -$5.03M Jul 1, 2018 Sep 30, 2018 10-K 2020-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.